Trials / Sponsors / Michael Choi
Michael Choi
Academic / Other · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 | 2018-05-01 |
| Withdrawn | Obinutuzumab With High-dose Ibrutinib for the Treatment of Patients With Chronic Lymphocytic Leukemia With Pro Chronic Lymphocytic Leukemia | Phase 1 | 2016-06-01 |
| Terminated | Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 | 2016-06-01 |